Glycyrrhizic Acid Biological Technology

Gansu Fanzhi Pharmaceutical, formerly known as Gansu Glycyrrhizic Acid Biological Technology, is a leading Chinese life sciences company specializing in the extraction and synthesis of licorice-derived compounds. As one of the world's largest producers of glycyrrhizic acid and its derivatives, the company provides high-purity active pharmaceutical ingredients (APIs) for the global pharmaceutical, cosmetic, and food industries. Its core product portfolio includes Monoammonium Glycyrrhizinate and Dipotassium Glycyrrhizinate, which are utilized for their potent anti-inflammatory and hepatoprotective effects. The company operates large-scale GMP-certified manufacturing facilities in the Gansu province, leveraging local natural resources to maintain a dominant position in the licorice extract market. Fanzhi Pharmaceutical exports its products to major markets including Japan, Europe, and North America, serving as a critical supplier for both traditional and modern medicine.